You have 9 free searches left this month | for more free features.

Sargramostim

Showing 476 - 500 of 536

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hormone Refractory Prostate Cancer Trial in Columbus (Sargramostim, Docetaxel, Prednisone)

Terminated
  • Hormone Refractory Prostate Cancer
  • Sargramostim
  • +2 more
  • Columbus, Ohio
    Veeda Oncology
May 9, 2012

Melanoma (Skin) Trial in Detroit (aldesleukin, autologous tumor cell vaccine, muromonab-CD3)

Completed
  • Melanoma (Skin)
  • aldesleukin
  • +4 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Apr 3, 2013

Leukemia Trial (biological, drug, procedure)

Completed
  • Leukemia
  • sargramostim
  • +4 more
  • (no location specified)
Jul 13, 2012

Lymphoma Trial in Atlanta (Mitoxantrone/Cyclophosphamide, Fludarabine, Rituximab and GM-CSF)

Terminated
  • Lymphoma
  • Mitoxantrone/Cyclophosphamide, Fludarabine, Rituximab and GM-CSF
  • Atlanta, Georgia
    Emory University Winship Cancer Institute
May 25, 2012

Colorectal Carcinoma Trial in Ottawa (Recombinant Vaccinia GM-CSF; RAC VAC GM-CSF (JX-594))

Terminated
  • Colorectal Carcinoma
  • Recombinant Vaccinia GM-CSF; RAC VAC GM-CSF (JX-594)
  • Ottawa, Ontario, Canada
    Ottawa Hospital and Research Institute (OHRI)
Apr 9, 2013

Prostate Cancer Trial in Durham (therapeutic autologous dendritic cells)

Terminated
  • Prostate Cancer
  • therapeutic autologous dendritic cells
  • Durham, North Carolina
    Duke Comprehensive Cancer Center
Mar 19, 2013

Primary Refractory Neuroblastoma Trial in United States (MAb-3F8, Subcutaneous Granulocyte Macrophage Colony Stimulating Factor

Terminated
  • Primary Refractory Neuroblastoma
  • MAb-3F8
  • +2 more
  • Phoenix, Arizona
  • +14 more
Feb 28, 2013

Lymphoma, Neutropenia Trial in Chicago (epoetin alfa, filgrastim, recombinant flt3 ligand)

Terminated
  • Lymphoma
  • Neutropenia
  • epoetin alfa
  • +5 more
  • Chicago, Illinois
    Robert H. Lurie Comprehensive Cancer Center, Northwestern Univer
May 31, 2012

Bladder Cancer Trial in United States (gemcitabine, cisplatin, sargramostim)

Terminated
  • Bladder Cancer
  • Louisville, Kentucky
  • +3 more
May 22, 2012

Malignant Melanoma Trial in Miami Beach, Atlanta (GM-CSF)

Completed
  • Malignant Melanoma
  • Miami Beach, Florida
  • +1 more
May 2, 2012

Nonneoplastic Condition Trial run by the CC (E1M184V peptide vaccine, incomplete Freund's adjuvant, sargramostim)

Completed
  • Nonneoplastic Condition
  • E1M184V peptide vaccine
  • +3 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Trials Refe
May 1, 2012

Colorectal Carcinoma Trial in Worldwide (Endoxana, Leukine, IMA910, Endoxana, Leukine, IMA910, Aldara)

Completed
  • Colorectal Carcinoma
  • Endoxana, Leukine, IMA910
  • Endoxana, Leukine, IMA910, Aldara
  • Bonheiden, Belgium
  • +40 more
May 15, 2013

Leukemia Trial in Boston (autologous tumor cell vaccine, therapeutic autologous dendritic cells, tumor cell-derivative vaccine

Terminated
  • Leukemia
  • autologous tumor cell vaccine
  • +2 more
  • Boston, Massachusetts
    Cancer Research Center at Boston Medical Center
Jan 3, 2013

Breast Tumors, Metastases, Tumor Trial in Bethesda, Hackensack (recombinant fowlpox-CEA(6D)/TRICOM vaccine, recombinant

Terminated
  • Breast Neoplasms
  • Metastases, Neoplasm
  • recombinant fowlpox-CEA(6D)/TRICOM vaccine
  • +8 more
  • Bethesda, Maryland
  • +1 more
Mar 20, 2012

Myasthenia Gravis Trial in Chicago (Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF))

Unknown status
  • Myasthenia Gravis
  • Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
  • Chicago, Illinois
    University of Illinois at Chicago, Department of Neurology
Mar 14, 2012

Breast Cancer, Colorectal Cancer, Lung Cancer Trial in Washington, Durham (denileukin diftitox, recombinant

Completed
  • Breast Cancer
  • +4 more
  • denileukin diftitox
  • +2 more
  • Washington, District of Columbia
  • +1 more
Nov 8, 2012

Lymphoma, Non Hodgkin's Lymphoma Trial in San Juan (Cyclophosphamide, Doxorubicin, Vincristine and Prednisone)

Completed
  • Lymphoma
  • Non Hodgkin's Lymphoma
  • Cyclophosphamide, Doxorubicin, Vincristine and Prednisone
  • San Juan, Puerto Rico
    Hospital Auxilio Mutuo Cancer Center
Feb 3, 2012

Leukemia Trial in United States (biological, drug, procedure, radiation)

Completed
  • Leukemia
  • sargramostim
  • +17 more
  • Aurora, Colorado
  • +93 more
Nov 21, 2012

Lymphoma Trial in Houston (Campath-1H, G-CSF, GM-CSF)

Terminated
  • Lymphoma
  • Houston, Texas
    UT MD Anderson Cancer Center
Nov 8, 2011

Leukemia Trial in Baltimore (recombinant interferon alfa, sargramostim)

Terminated
  • Leukemia
  • recombinant interferon alfa
  • sargramostim
  • Baltimore, Maryland
    Johns Hopkins Oncology Center
Jul 19, 2011

Leukemia Trial in Baltimore (sargramostim, therapeutic allogeneic lymphocytes, allogeneic bone marrow transplantation)

Terminated
  • Leukemia
  • sargramostim
  • +3 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jul 19, 2011

Renal Cell Carcinoma Trial in Worldwide (Endoxana, IMA901, Leukine, IMA901 and Leukine)

Completed
  • Renal Cell Carcinoma
  • Endoxana, IMA901, Leukine
  • IMA901 and Leukine
  • Salzburg, Austria
  • +43 more
Jul 9, 2012

Leukemia Trial in Baltimore (autologous tumor cell vaccine, rituximab, cyclophosphamide)

Withdrawn
  • Leukemia
  • autologous tumor cell vaccine
  • +2 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
May 1, 2012

Metastatic Cancer, Sarcoma Trial (biological, drug, other, procedure, radiation)

Completed
  • Metastatic Cancer
  • Sarcoma
  • aerosol sargramostim
  • +14 more
  • (no location specified)
May 13, 2011

Melanoma (Skin) Trial in United States (MART-1 antigen, gp100 antigen, incomplete Freund's adjuvant)

Completed
  • Melanoma (Skin)
  • MART-1 antigen
  • +5 more
  • Scottsdale, Arizona
  • +31 more
Nov 5, 2011